IQVIA Pharma Deals Half-Year Review of 2019
White Paper
Sep 06, 2019

The IQVIA Pharma Deals Half-Year Review of 2019 provides an insightful overview of deal activity in the first half of 2019, as well as an outlook for the remainder of 2019. Key information provided includes the following:

  • Top M&A and partnership deals of H1 2019
  • Deal activity rankings of the top pharmaceutical companies
  • Therapeutic area and development phase deal activity
  • Deal value analysis of M&A, licensing and R&D deals

 

Key Highlights

  • Big-ticket M&A returned to the biopharmaceutical sector, driving an upturn in M&A deal values
  • Bucking the downward trend seen in previous years, the number of collaborative R&D agreements was up in H1 2019 with deals becoming increasingly broad
Get more details about IQVIA Pharma Deals today.
Request a demo
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.